Stivarga 40 mg/1
regorafenib · TABLET, FILM COATED · Bayer HealthCare Pharmaceuticals Inc.
Stivarga is a tablet, film coated containing regorafenib at 40 mg/1, taken oral. Manufactured by Bayer HealthCare Pharmaceuticals Inc..
Key Facts
- Brand Name
- Stivarga
- Generic Name
- regorafenib
- NDC Code (Product)
50419-171- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 40 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA203085
- Marketing Start
- 09/27/2012
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Stivarga used for?
Stivarga contains regorafenib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Stivarga a controlled substance?
Stivarga is not classified as a controlled substance by the DEA.
What is the generic name for Stivarga?
The generic name for Stivarga is regorafenib. There are no other listed brand versions of regorafenib.
What is the NDC code for Stivarga 40 mg/1?
The NDC (National Drug Code) for Stivarga 40 mg/1 is 50419-171, listed by Bayer HealthCare Pharmaceuticals Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)